Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 01, 2025 11:00 ET | Source: Zealand Pharma

REMINDER: Zealand Pharma’s Capital Markets Day on December 11, 2025

Press release – No. 17 / 2025 REMINDER: Zealand Pharma’s Capital Markets Day on December 11, 2025 Copenhagen, Denmark, December 1, 2025 - Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078), a...
November 24, 2025 16:05 ET | Source: Rani Therapeutics, LLC

Rani Therapeutics to Participate in the Evercore Healthcare Conference

SAN JOSE, Calif., Nov. 24, 2025 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral...
November 24, 2025 07:00 ET | Source: Biomea Fusion, Inc.

Biomea Fusion to Participate at Upcoming Investor Conferences

SAN CARLOS, Calif., Nov. 24, 2025 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea” or “Biomea Fusion” or “the Company”) (Nasdaq: BMEA), a clinical-stage diabetes and obesity company, today...
November 12, 2025 09:00 ET | Source: Mochi Health

Mochi Health Expands Beyond Obesity Care with Comprehensive Digital Health Platform, Adding 15 New Categories of Care

SAN FRANCISCO, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Mochi Health, an evidence-based medicine platform that connects patients with providers, today announced the strategic expansion of its digital...
November 06, 2025 16:30 ET | Source: Rani Therapeutics, LLC

Rani Therapeutics Reports Third Quarter 2025 Financial Results; Provides Corporate Update

– Announced up to $1.085 billion collaboration with Chugai Pharmaceutical Co. for multiple high-value therapeutics – – Completed $60.3 million oversubscribed private placement led by Samsara...
November 05, 2025 08:00 ET | Source: Kailera Therapeutics, Inc.

Kailera Therapeutics to Participate in Upcoming November Investor Conferences

Kailera will participate in several upcoming investor conferences in November: Stifel HC Conf, Jefferies London HC Conf, TD Cowen Obesity Summit
November 04, 2025 12:00 ET | Source: Rivus Pharmaceuticals, Inc.

Rivus Pharmaceuticals Presents Preclinical Data for Controlled Metabolic Accelerator (CMA) Pipeline Showing Fat-Selective, Muscle-Preserving Weight Loss in Obesity at ObesityWeek®

First data from Rivus’ preclinical CMA pipeline showing potential as monotherapy and in combination with GLP-1s
November 04, 2025 12:00 ET | Source: Kailera Therapeutics, Inc.; Hengrui Pharma

Hengrui Pharma and Kailera Therapeutics Announce Additional Data from Phase 3 Obesity Trial in China of Dual GLP-1/GIP Receptor Agonist HRS9531

Hengrui Pharma & Kailera Therapeutics Present Additional Data from Phase 3 Trial in China of Dual GLP-1/GIP Receptor Agonist HRS9531 at Obesity Week
November 03, 2025 07:30 ET | Source: Kailera Therapeutics, Inc.

Kailera Therapeutics Appoints Frank Clyburn to Board of Directors

Kailera Therapeutics appoints 30-year biopharma industry veteran Frank Clyburn, Jr to its Board of Directors
October 30, 2025 08:00 ET | Source: Rani Therapeutics, LLC

Rani Therapeutics to Present Preclinical Data on Oral Delivery of Semaglutide via the RaniPill® Capsule at ObesityWeek® 2025

SAN JOSE, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral...